Key facts
- This page summarizes Matthew Dyer's Form 4 filing for Quantum-Si Inc (QSI).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 15 Jun 2022, 16:12.
Matthew Dyer - 13 Jun 2022 Form 4 Insider Report for Quantum-Si Inc (QSI)
- Reporting relationship
- Chief Business Officer
- Issuer ticker
- QSI
- Reported as of
- 13 Jun 2022
- Net transaction value
- -$5,223
- SEC form
- 4
- Accepted by SEC
- 15 Jun 2022, 16:12:24 UTC
- Prior SEC filing
- 16 Mar 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Christian LaPointe, Ph.D., Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Matthew Dyer filed Form 4 for Quantum-Si Inc (QSI) on 15 Jun 2022.
Change
- Previous filing in this sequence was filed on 16 Mar 2022.
- Current net transaction value: -$5,223.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
QSI
transaction
Class A Common Stock
Sale
- Transaction value
- $5,223
- Shares
- -1,622
- Change %
- -0.48%
- Price
- $3.22
- Shares after
- 333,393
- Date
- 13 Jun 2022
- Ownership
- Direct
- Footnotes
- F1, F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Matthew Dyer is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 3 footnotes
Footnote F1
The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") that were granted on March 12, 2021 pursuant to a "sell to cover" provision included in the RSU Agreement.
Footnote F2
Represents the weighted average sales price per share. The shares sold at prices ranging from $3.14 to $3.28 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
Footnote F3
Includes 54,826 RSUs. Each RSU represents the right to receive one share of common stock upon vesting. 4,985 RSUs vested on June 12, 2022, with 54,826 RSUs vesting in 11 equal quarterly installments thereafter, subject to Dr. Dyer's continued service through the applicable vesting date.